Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Galluzzo

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|April 3, 2021
Quality of Life and Psychological Impact in Patients with Atopic DermatitisMarina Talamonti, Marco Galluzzo, Dionisio Silvaggio, et al.
JAAD Case Reports|October 21, 2024
Eczematous liraglutide eruption managed by dupilumab: A case reportClaudia Paganini, Alfredo Belcastro, Angela Fico, et al.
Dermatologic Therapy|April 11, 2019
Successful treatment of psoriatic crumbly nails with ustekinumabMarco Galluzzo, Simone D'Adamio, Maria Sole Chimenti, et al.
Dermatology (Basel, Switzerland)|November 18, 2014
What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practiceMarina Talamonti, Marco Galluzzo, Luca Bianchi, et al.
Journal of Dermatological Case Reports|April 13, 2013
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilarisAlessandro Di Stefani, Marco Galluzzo, Marina Talamonti, et al.
Dermatology Reports|May 13, 2026
Efficacy and safety of mogamulizumab in Sézary syndrome with concomitant Crohn's diseaseCosimo Di Raimondo, Edoardo Mortato, Pier Paolo Di Domenico, et al.
Journal of Clinical Medicine|February 10, 2024
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 WeeksClaudia Paganini, Marina Talamonti, Virginia Maffei, et al.
International Journal of Dermatology|June 27, 2025
Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life StudyEdoardo Mortato, Marina Talamonti, Claudia Paganini, et al.
International Journal of Dermatology|January 7, 2026
Predictive Factors of Super-Responder Status to Dupilumab in Adult Atopic Dermatitis: A Real-World Monocentric StudyEdoardo Mortato, Marina Talamonti, Claudia Paganini, et al.
Expert Opinion on Biological Therapy|December 19, 2017
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patientsMarco Galluzzo, Simone D'Adamio, Roberta Pastorino, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|April 3, 2021
Quality of Life and Psychological Impact in Patients with Atopic DermatitisMarina Talamonti, Marco Galluzzo, Dionisio Silvaggio, et al.
JAAD Case Reports|October 21, 2024
Eczematous liraglutide eruption managed by dupilumab: A case reportClaudia Paganini, Alfredo Belcastro, Angela Fico, et al.
Dermatologic Therapy|April 11, 2019
Successful treatment of psoriatic crumbly nails with ustekinumabMarco Galluzzo, Simone D'Adamio, Maria Sole Chimenti, et al.
Dermatology (Basel, Switzerland)|November 18, 2014
What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practiceMarina Talamonti, Marco Galluzzo, Luca Bianchi, et al.
Journal of Dermatological Case Reports|April 13, 2013
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilarisAlessandro Di Stefani, Marco Galluzzo, Marina Talamonti, et al.
Dermatology Reports|May 13, 2026
Efficacy and safety of mogamulizumab in Sézary syndrome with concomitant Crohn's diseaseCosimo Di Raimondo, Edoardo Mortato, Pier Paolo Di Domenico, et al.
Journal of Clinical Medicine|February 10, 2024
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 WeeksClaudia Paganini, Marina Talamonti, Virginia Maffei, et al.
International Journal of Dermatology|June 27, 2025
Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life StudyEdoardo Mortato, Marina Talamonti, Claudia Paganini, et al.
International Journal of Dermatology|January 7, 2026
Predictive Factors of Super-Responder Status to Dupilumab in Adult Atopic Dermatitis: A Real-World Monocentric StudyEdoardo Mortato, Marina Talamonti, Claudia Paganini, et al.
Expert Opinion on Biological Therapy|December 19, 2017
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patientsMarco Galluzzo, Simone D'Adamio, Roberta Pastorino, et al.
Pageof 12